Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 2;85(7):3730-8.
doi: 10.1021/ac3037365. Epub 2013 Mar 18.

Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search

Affiliations

Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search

Ariane Wohlfarth et al. Anal Chem. .

Abstract

Introduction: Synthetic cannabinoids are an emerging illicit drug class. The variety of available substances is large and ever-changing, making it difficult for laboratories to remain current. We present a qualitative LC-MS/MS method identifying urinary metabolites of JWH-018, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-250, RCS-4, and AM2201 and the parent compounds JWH-018, JWH-073, JWH-081, JWH-122, JWH-210, JWH-250, RCS-4, AM2201, and MAM2201.

Methods: After enzymatic hydrolysis, urinary proteins were precipitated with acetonitrile. Chromatography utilized a 10 min gradient on a Kinetex XB-C18 column with 0.1% formic acid in water and acetonitrile. Scheduled multiple reaction monitoring "survey scans" were followed by information-dependent acquisition-enhanced product ion scan experiments on an ABSciex 5500 QTRAP mass spectrometer. Analytes were identified by software-assisted library searching against reference spectra.

Results: The method was fully validated, including proof of selectivity (no exogenous or endogenous interferences were observed), assessment of matrix effects (95-122%) and recovery (53-95%), determination of limits of detection (0.5-10 ng/mL), carry-over studies (thresholds between 100 and 1000 ng/mL), and determination of autosampler stability (samples were stable for at least 3 days). Hydrolysis efficiency was thoroughly investigated for a wide range of glucuronides and for the reference standard, JWH-018 5-hydroxypentyl glucuronide.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of synthetic cannabinoid parent compounds included in the method.
Figure 2
Figure 2
Total ion chromatograms of an LOD control at 5 ng/mL with (A) sMRM and EPI triggering and (B) unscheduled MRM. 1a, JWH-018; 1b, JWH-018 5-hydroxypentyl; 1c, JWH-018 6-hydroxyindole; 1d, JWH-018 5-hydroxyindole; 1e, JWH-018 pentanoic acid; 2a, JWH-073; 2b, JWH-073 4-hydroxybutyl; 2c, JWH-073 6-hydroxyindole; 2d, JWH-073 5-hydroxyindole; 2e, JWH-073 butanoic acid; 3a, JWH-081; 3b, JWH-081 5-hydroxypentyl; 4a, JWH-122; 4b, JWH-122 5-hydroxypentyl; 5a, JWH-200 5-hydroxyindole; 5b, JWH-200 6-hydroxyindole; 6a, JWH-210; 6b, JWH-210 5-hydroxypentyl; 6c, JWH-210 4-hydroxypentyl; 6d, JWH-210 5-hydroxyindole; 6e, JWH-210 pentanoic acid; 7a, JWH-250; 7b, JWH-250 5-hydroxypentyl; 7c, JWH-250 4-hydroxypentyl; 7d, JWH-250 5-hydroxyindole; 7e, JWH-250 pentanoic acid; 8a, RCS-4; 8b, RCS-4 5-hydroxypentyl; 8c, RCS-4 pentanoic acid; 9a, AM2201; 9b, AM2201 4-hydroxypentyl; 9c, AM2201 6-ydroxyindole; 10a, MAM2201.
Figure 3
Figure 3
Library search with LibraryView for AM2201 4-hydroxypentyl (4.86 min retention time) in an LOD control sample at 2.5 ng/mL and in an authentic urine sample.

References

    1. European Monitoring Centre for Drugs and Drug Abuse. European Database on New Drugs. 2012
    1. Swiss Confederation. SR 812.121.11. 2011
    1. U.S. Government. Synthetic Drug Abuse Prevention Act. 2012:138–139.
    1. Sobolevsky T, Prasolov I, Rodchenkov G. Drug Test Anal. 2012;4:745–753. - PubMed
    1. Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, James LP, Hollenberg PF, Prather PL, Radominska-Pandya A, Moran JH. Drug Metab Dispos. 2012;40:2174–84. - PMC - PubMed

Publication types